Clinical Trial Cancer Mission 2020 Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 6, 2013)
Clinical Trial Cancer Mission 2020 Act - Revises clinical trial registry data bank provisions of the Public Health Service Act to: (1) include a device or drug clinical trial whether or not it results in a positive or negative outcome, and (2) subject clinical trials funded by the Department of Defense (DOD) to requirements to certify information submissions to the Director of the National Institutes of Health (NIH).
Restricts funding for a grantee and makes the grantee liable to the United States for repayment of any grant amount provided, if the grantee has not submitted clinical trial information within the 30-day correction period for noncompliance.
What just happenedJun 7, 2013
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 6, 2013
- Jun 7, 2013Committee
Referred to the Subcommittee on Health.
- Jun 6, 2013IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
- Jun 6, 2013IntroReferralIntro-H
Introduced in House
- Jun 6, 2013IntroReferral1000
Introduced in House